Sensex hits 43,000-mark for first time, rises 1.6%
Extending its winning streak for the seventh straight session, the equity benchmark Sensex soared 680 points to scale another lifetime high, tracking a global market rally driven by Pfizer’s COVID-19 vaccine trials data.
- After touching its lifetime peak of 43,316.44 during the day, the 30-share BSE index settled 680.22 points, or 1.6%, higher at 43,277.65.
- The broader NSE Nifty touched a fresh intraday high of 12,643.90. It closed 170.05 points, or 1.36%, higher at 12,631.10.
- Bajaj Finance was the top gainer in the Sensex pack, surging about 9%, followed by IndusInd Bank, L&T, Bajaj Finserv, HDFC, SBI, ICICI Bank, HDFC Bank, ONGC and Axis Bank. On the other hand, Tech Mahindra, HCL Tech, Infosys, Nestle India, Sun Pharma and TCS closed in the red.
- Announcements by BioNTech and Pfizer about successful phase-3 trials of their COVID-19 vaccine instilled confidence among investors and possibility of sustained economic recovery led sharp buying in beaten down stocks.